Addex Announces Participation in the 22nd Bio€quity Europe Conference
Geneva, Switzerland, May 13, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug...
Day: May 13, 2022
Plantable Health Inc. Announces March 2022 First Quarter Financial Results
New York, New York--(Newsfile Corp. - May 13, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the...
Harvest One Announces Supply Agreement with Canopy Growth’s Spectrum Therapeutics’ Online Medical Store
Products to be Supplied via an Extension of the Company's Licensing Agreement with The Valens CompanyVancouver, British Columbia--(Newsfile Corp. -...
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
NEW YORK--(BUSINESS WIRE)--$LUCD #Biotech--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid...
Invitation to Conference Call Regarding Promore Pharma’s Interim Report for the First Quarter 2022
STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 13 May 2022 - Promore Pharma AB (publ)...